The U.S. Food and Drug Administration has issued an alert concerning reports of liver injury in patients taking Prezista. The FDA said Prezista (darunavir), an anti-retroviral drug used to treat for the human immunodeficiency virus HIV, is suspected of contributing to several hepatic events, including liver failure, destruction of liver tissue, cirrhosis, hepatitis and jaundice.
Read article at physorg.com
Comment: All anti-retroviral drugs are toxic.
Thursday, April 03, 2008
FDA issues alert about HIV drug Prezista
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";